Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,448 | -355,928 | -245,197 | -161,934 | -180,617 |
| Depreciation Amortization | 3,614 | 11,070 | 7,735 | 4,853 | 2,247 |
| Accounts payable and accrued liabilities | 1,917 | -266 | 1,397 | -373 | 1,599 |
| Other Working Capital | -3,361 | 9,801 | 11,338 | 5,672 | -3,136 |
| Other Operating Activity | -48,431 | 84,269 | 83,772 | 61,313 | 129,994 |
| Operating Cash Flow | $-77,709 | $-251,054 | $-140,955 | $-90,469 | $-49,913 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,533 | -29,862 | -24,660 | -16,596 | -6,440 |
| Purchase Of Investment | -25,675 | -491,387 | -414,437 | -165,551 | -44,811 |
| Sale Of Investment | 45,753 | 280,025 | 266,960 | 195,914 | 100,342 |
| Other Investing Activity | 0 | -4,574 | 0 | 0 | 0 |
| Investing Cash Flow | $12,545 | $-245,798 | $-172,137 | $13,767 | $49,091 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 652 | 631,751 | 628,632 | 627,036 | 626,703 |
| Financing Cash Flow | $652 | $631,751 | $628,632 | $627,036 | $626,703 |
| Beginning Cash Position | 261,848 | 126,949 | 126,949 | 126,949 | 126,949 |
| End Cash Position | 197,336 | 261,848 | 442,489 | 677,283 | 752,830 |
| Net Cash Flow | $-64,512 | $134,899 | $315,540 | $550,334 | $625,881 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,709 | -251,054 | -140,955 | -90,469 | -49,913 |
| Capital Expenditure | -7,533 | -29,862 | -24,660 | -16,596 | -6,440 |
| Free Cash Flow | -85,242 | -280,916 | -165,615 | -107,065 | -56,353 |